The Patent Finder
PA

Pharmaceutical Advisors LLC

First filing 2022
OverviewNotableFeesChangesPatent listSources & methods

0 patents currently held, every record listed here

3 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

This portfolio holds none of the 3 US patents in force on its record. from the record

Of the 3 now held by other companies, 2 name Empathbio Inc. as their current owner, and 1 more name another party. Each row says which.

Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
0
Ending by 2030
none
Next term end

When these terms end

Each bar runs from grant to computed term end. 2024 to 2044.
US 12,378,194 New N,n-Dimethyltryptamine Salts and Crystalline Salt Forms May 25, 2042
US 11,993,577 Synthesis of Mdma or Its Optically Active (R)- or (S)-Mdma Isomers Sep 1, 2042
US 12,715,852 Preparation of Optically Active Enantiomers of Piperonyl Amines by Resolution of the Diastereomeric Salts Oct 8, 2044
20282032203620402044
Every computed term in this portfolio is shown above.Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know

Notable patents

Ranked by citations and family size, against patents of the same kind granted the same year. How we rank
None of the currently held patents qualifies as notable.

Formerly held, still cited

Notable
Granted 2025. Too new for citation comparison; protection runs to 2042.
Ends May 2042 · High confidence

Fee deadlines

No maintenance fee falls due on this company's record before Nov 10, 2027.

Recent changes

  • 1 of the patents on this record was granted since Aug 17, 2026

Patents held now

Soonest term end first.
Also on record: 3 patents in force now held by others. List them

Sources and methods

Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited